Skip to main content

Advertisement

Log in

Epidermal differentiation complex protein involucrin is down-regulated in eosinophilic esophagitis

  • Original Article
  • Published:
Esophagus Aims and scope Submit manuscript

Abstract

Background and aims

Epidermal differential complex (EDC) proteins, such as filaggrin, involucrin, and loricrin, play key roles to protect the mucosal surface against invading pathogens. Eosinophilic esophagitis (EoE) is an allergic gastrointestinal disease that features eosinophilic infiltration of esophageal mucosa, though the function of EDC proteins in its pathogenesis remains unknown. The aim of this study was to investigate possible differences of EDC protein expression in the epithelium of the esophagus, pharynx, and tongue. Furthermore, we examined that expression in esophageal specimens obtained from patients with EoE.

Methods

For evaluating EDC protein expression in epithelium from different locations, we enrolled 72 patients who underwent surgical resection for esophageal, pharyngeal, or tongue squamous cell carcinoma. Pathological samples were used for analysis of expression by immunohistochemistry. In addition, samples were obtained from 10 patients with EoE and 11 healthy subjects, and compared for esophageal epithelial expression of EDC proteins.

Results

In epithelium samples obtained from the esophagus, pharynx, and tongue, the presence of EDC proteins was confirmed by immunohistochemistry analysis findings, though the expression patterns were notably different in comparison to that in epidermis samples. In EoE patients, the expression of involucrin was dramatically down-regulated in esophageal mucosa, whereas down-regulation of filaggrin and loricrin did not reach a statistically significant level.

Conclusion

EDC protein expression was clearly detected in pharyngoesophageal epithelium samples, while that of involucrin alone was markedly reduced in patients with EoE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Asher MI, Montefort S, Björkstén B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368(9537):733–43.

    Article  PubMed  Google Scholar 

  2. Wesemann DR, Nagler CR. The Microbiome, timing, and barrier function in the context of allergic disease. Immunity. 2016;44(4):728–38.

    Article  CAS  PubMed  Google Scholar 

  3. Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol. 2005;6(4):328–40.

    Article  CAS  PubMed  Google Scholar 

  4. Kypriotou M, Huber M, Hohl D. The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the ‘fused genes’ family. Exp Dermatol. 2012;21(9):643–9.

    Article  CAS  PubMed  Google Scholar 

  5. Listwan P, Rothnagel JA. Keratin bundling proteins. Methods Cell Biol. 2004;78:817–27.

    Article  CAS  PubMed  Google Scholar 

  6. Eckert RL, Crish JF, Efimova T, et al. Regulation of involucrin gene expression. J Invest Dermatol. 2004;123(1):13–22.

    Article  CAS  PubMed  Google Scholar 

  7. Iizuka H, Takahashi H, Honma M, Ishida-Yamamoto A. Unique keratinization process in psoriasis: late differentiation markers are abolished because of the premature cell death. J Dermatol. 2004;31(4):271–6.

    Article  PubMed  Google Scholar 

  8. Marenholz I, Volz A, Ziegler A, et al. Genetic analysis of the epidermal differentiation complex (EDC) on human chromosome 1q21: chromosomal orientation, new markers, and a 6-Mb YAC contig. Genomics. 1996;37(3):295–302.

    Article  CAS  PubMed  Google Scholar 

  9. Kinoshita Y, Furuta K, Ishimaura N, et al. Clinical characteristics of Japanese patients with eosinophilic esophagitis and eosinophilic gastroenteritis. J Gastroenterol. 2013;48(3):333–9.

    Article  PubMed  Google Scholar 

  10. Rothenberg ME. Molecular, genetic, and cellular bases for treating eosinophilic esophagitis. Gastroenterology. 2015;148(6):1143–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Kinoshita Y, Ishimura N, Oshima N, et al. Recent progress in the research of eosinophilic esophagitis and gastroenteritis. Digestion. 2016;93(1):7–12.

    Article  PubMed  Google Scholar 

  12. Kinoshita Y, Ishimura N, Mishiro T, et al. Diagnosis and treatment of eosiniophilic esophagitis in Japan. Esophagus. 2016;. doi:10.1007/s10388-016-0550-8.

    Google Scholar 

  13. Ishimura N, Furuta K, Sato S, Ishihara S, Kinoshita Y. Limited role of allergy testing in patients with eosinophilic gastrointestinal disorders. J Gastroenterol Hepatol. 2013;28(8):1306–13.

    Article  CAS  PubMed  Google Scholar 

  14. Ishimura N, Shimura S, Jiao D, et al. Clinical features of eosinophilic esophagitis: differences between Asian and Western populations. J Gastroenterol Hepatol. 2015;30(Suppl 1):71–7.

    Article  PubMed  Google Scholar 

  15. Simon D, Radonjic-Hosli S, Straumann A, Yousefi S, Simon HU. Active eosinophilic esophagitis is characterized by epithelial barrier defects and eosinophil extracellular trap formation. Allergy. 2015;70(4):443–52.

    Article  CAS  PubMed  Google Scholar 

  16. Blanchard C, Wang N, Stringer KF, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest. 2006;116(2):536–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Blanchard C, Stucke EM, Burwinkel K, et al. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol. 2010;184(7):4033–41.

    Article  CAS  PubMed  Google Scholar 

  18. Wawrzyniak P, Akdis CA, Finkelman FD, Rothenberg ME. Advances and highlights in mechanisms of allergic disease in 2015. J Allergy Clin Immunol. 2016;137(6):1681–96.

    Article  CAS  PubMed  Google Scholar 

  19. Weidinger S, Illig T, Baurecht H, et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol. 2006;118(1):214–9.

    Article  CAS  PubMed  Google Scholar 

  20. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38(4):441–6.

    Article  CAS  PubMed  Google Scholar 

  21. Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. 2011;365(14):1315–27.

    Article  CAS  PubMed  Google Scholar 

  22. Jiao D, Ishimura N, Maruyama R, et al. Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients. J Gastroenterol. 2016. doi:10.1007/s00535-016-1213-1.

    PubMed  Google Scholar 

  23. Vighi G, Marcucci F, Sensi L, Di Cara G, Frati F. Allergy and the gastrointestinal system. Clin Exp Immunol. 2008;153(Suppl 1):3–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Kim BE, Howell MD, Guttman-Yassky E, et al. TNF-alpha downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-alpha antagonists to improve skin barrier. J Invest Dermatol. 2011;131(6):1272–9.

    Article  CAS  PubMed  Google Scholar 

  25. McAleer MA, Irvine AD. The multifunctional role of filaggrin in allergic skin disease. J Allergy Clin Immunol. 2013;131(2):280–91.

    Article  CAS  PubMed  Google Scholar 

  26. Jiang M, Ku WY, Zhou Z, et al. BMP-driven NRF2 activation in esophageal basal cell differentiation and eosinophilic esophagitis. J Clin Invest. 2015;125(4):1557–68.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Shoda T, Morita H, Nomura I, et al. Comparison of gene expression profiles in eosinophilic esophagitis (EoE) between Japan and Western countries. Allergol Int. 2015;64(3):260–5.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Akira Yasuda (Department of Medical Informatics, Shimane University School of Medicine) for support regarding statistical analysis. This study was supported by the Health and Labour Sciences Research Grants for research on intractable diseases from the Ministry of Health, Labour and Welfare of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Naoki Oshima.

Ethics declarations

Ethical Statement

The present study was performed at the Shimane University Hospital in accordance with the Declaration of Helsinki and the protocol was approved by the ethics committee of the Shimane University School of Medicine. Written informed consent was obtained from all subjects. This study was registered with the University Hospital Medical Information Network (UMIN) clinical trials registry (UMIN 000022242).

Conflicts of interest

Yoshikazu Kinoshita has received honoraria from AstraZeneca, Daiichi-Sankyo, EA Pharma, Otsuka, and Takeda Pharmaceutical.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oshima, N., Ishihara, S., Fukuba, N. et al. Epidermal differentiation complex protein involucrin is down-regulated in eosinophilic esophagitis. Esophagus 14, 171–177 (2017). https://doi.org/10.1007/s10388-016-0568-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10388-016-0568-y

Keywords

Navigation